B. Frank Gupton, Ph.D.
B. Frank Gupton, Ph.D.
B. Frank Gupton, Ph.D., is the Floyd D. Gottwald Professor and Chair of the Department of Chemical and Life Science Engineering at the Virginia Commonwealth University School of Engineering. His thirty year industrial career has centered on the development and commercialization of chemical processes for pharmaceutical and agricultural applications. As Executive Director of Chemical Process Development at Boehringer Ingelheim Pharmaceuticals, he led the development and commercialization of the chemical process for the production of Nevirapine, a widely-prescribed antiviral medication for the treatment of AIDS. Gupton holds a B.S. in chemistry from the University of Richmond, an M. S. in biochemistry from the Georgia Institute of Technology, and a Ph.D. in chemistry from VCU.
Mike Osberg, MPP
Mike Osberg, MPP
Mike Osberg is the Chief Commercial and Strategy Officer at Medicines for All. Before joining M4ALL, Mike was a Director at Linksbridge SPC, where he led a portfolio of work focused on global health priorities including TB, HIV, NTDs, malaria, and polio. He led the creation and launch of several products to support these activities, including the TB Patient Pathway Analysis, which the Global Fund and World Health Organization recommended as a priority method to inform TB strategy globally. He has also led projects focused on strategy development, cost-benefit analysis, demand forecasting, and market assessment for organizations including the Bill & Melinda Gates Foundation, the WHO, PATH, KNCV, and several national TB programs.
Before Linksbridge, Mike built financial tools for several technology companies and worked in policy research at the non-partisan research department of the Minnesota House of Representatives.
Mike holds a Master of Public Policy from the Hubert H. Humphrey School of Public Affairs at the University of Minnesota and a B.A. in Economics from the University of Wisconsin-Madison.
Ryan Littich, Ph.D.
Ryan Littich, Ph.D.
`